Reflexion Pharmaceuticals
Business Services · United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
United StatesWebsite
www.reflexionpharma.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Reflexion Pharmaceuticals
Use tab to navigate through the menu items. AN ENTIRELY NEW CLASS OF THERAPEUTICS: SYNTHETIC D-PROTEINS Reflexion Pharmaceuticals has developed a novel platform utilizing the tools of synthetic biology to discover, develop and deliver an exciting new class of drug products: proteins composed entirely of D-amino acids. Synthetic D-proteins retain the benefits of antibodies while overcoming many of their limitations including reduced visibility, reduced size, improved stability and unique functionality. We believe our platform has enormous potential as synthetic D-proteins can be made to over 80% of the proteins currently targeted by antibody drugs, as well as additional targets. Reflexion has developed a platform utilizing the tools of synthetic chemical biology to discover, develop and deliver an entirely new class of therapeutics: novel synthetic D-proteins. These synthetic D-proteins are expected to exhibit many of the benefits of monoclonal antibodies while overcoming many of theirRead more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Reflexion Pharmaceuticals your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Reflexion Pharmaceuticals is spiking on competitors!
Funding: Get notified immidiatlly once Reflexion Pharmaceuticals has new funding data
Earning: See what the market has to say on Reflexion Pharmaceuticals recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Reflexion Pharmaceuticals
Product Launch: Get notified when Reflexion Pharmaceuticals launches new products
Check if Reflexion Pharmaceuticals has recently received funding, and reach out quickly before it becomes old news!
Reflexion Pharmaceuticals, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Reflexion Pharmaceuticals had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Recommended Actions
Find VP level buyers at Reflexion Pharmaceuticals
Find 3 more new buyers
Compare Similar Companies to Reflexion Pharmaceuticals
Compare insights from companies similar to Reflexion Pharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Reflexion Pharmaceuticals
<$5M
1-10
Private
-
-
N/A
Company Profile Activity
Activity Insights
Reflexion Pharmaceuticals is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Reflexion Pharmaceuticals is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Reflexion Pharmaceuticals.
Reflexion Pharmaceuticals Tech Stack
A closer look at the technologies used by Reflexion Pharmaceuticals
Top Business Services Companies
Top companies in Australia by revenue
Frequently Asked Questions Regarding Reflexion Pharmaceuticals
Sign Up For FreeTo access detailed company insights
Use tab to navigate through the menu items. AN ENTIRELY NEW CLASS OF THERAPEUTICS: SYNTHETIC D-PROTEINS Reflexion Pharmaceuticals has developed a novel platform utilizing the tools of synthetic biology to discover, develop and deliver an exciting new class of drug products: proteins composed entirely of D-amino acids. Synthetic D-proteins retain th... Read More
